For Germany’s Merck, China remains a sweet pill


Merck, the German science and technology company, will continue to invest in digital transformation, pharmaceutical innovation and collaboration with local partners in China to maintain robust growth in the coming years, said a senior executive.

China's pursuit in high-quality and high-efficacy medications, and its efforts in alleviating the burden for both...